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ABSTRACT 
Louis-Ferdinand, Robert Thomas, Ph.D. , University of Rhode Island 
August, 1969. The Modification of Hepatic Microsomal Drug Metabolism by 
Phenobarbital and Amphetamine. Major Professor: Dr. George C. Fuller. 
This investigation was carried out to provide a mechanistic explanation 
for the modification of hepatic microsomal drug metabolism produced by am-
phetamine· and phenobarbital. The influence of phenobarbital administration 
on the activity of microsomal ribonuclease during induction of drug-metabolizing 
enzymes, was determined. Administration of phenobarbital (100 mg/kg) for 
six days resulted in a significant (P .£0. 05) increase in hepatic microsomal 
oxidative demethylation. Conversely, hepatic microsomal ribonuclease activity 
of phenobarbital-treated rats was significantly reduced to less than 5% of control 
values. When phenobarbital (50 mg/kg) was administered for 5 days ribonuclease 
activity was inhibited to about one-half of control values. Phenolpthalein 
{3-glucuronidase activity of hepatic microsomal fractions obtained from pheno-
barbital treated animals was not significantly (P) O. 05) different from controls. 
Phenobarbital(lxlo-\1olar) did not inhibit ribonuclease activity following in vitro 
additions to the assay system. Time-response studies were. conducted following 
the administration of a single dose of phenobarbital (100 mg/kg). Results of 
these studies indicated that microsomal p-chloro-N-methylaniline (PCMA) 
demethylase stimulation and ribonuclease inhibition were temporaily related, 
except for a 24 hour lag in the PCMA demethylase response. Administration of 
phenobarbital (50 mg/kg twice-daily) produced significant inhibition of ribo-
nuclease and stimulaticn of drug metabolism in liver microsomes of intact, 
adrenalectomized or hypophysectomized rats. Administration of 3-methyl-
cholanthrene (40 mg/kg) to male rats resulted in a non-significant inhibition 
of ribonuclease activity while p-nitroanisole demethylation was stimulated 
three-fold. In vitro recombination experiments in which 105, 000 x g rat liver 
supernatants from control and treated animals were combined ·with rnicrosomes 
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I. INTRODUCTION 
Since the duration of action of many drugs is determined by the rate 
of hepatic drug-metabolism, (Conney, 1967) the pharmacological stimulation 
or inhibition of drug biotransformation is a mechanism responsible for many 
drug interactions. This thesis includes two independent investigations; one is 
designed to elucidate the mechanism of action of a drug which stimulates 
hepatic drug metabolism (Phenobarbital). 
The phenomenon of enzyme induction (increased amount of enzyme) has 
long been a subject of interest to biochemists because of the key role this 
phenomenon plays in metabolism. However, the precise mechanisms involved 
in the regulation of many inducible enzymes are poorly understood. In addition 
to the apparent pharmacological significance of such a phenomenon, it is 
probable that investigations into the nature of the enhancement of drug-metaboliz-
ing systems can yield information relating to the general problem of the mechanism 
of substrate-induced synthesis of an organized multienzyme system. 
After the first report of induction of hepatic microsomal drug metabolism 
(Brown et al. , (19 54) numerous investigators have demonstrated that the activity 
of microsomal enzymes can be markedly influenced by the exposure of mammalian 
or non-mammalian organisms to a variety of foreign compounds (Conney, 1965). 
The enzyme inducers most frequently studied, phenobarbital (Pb) and 3-methyl-
cholanthrene (MC) reportedly increase enzyme levels through enhanced de ~ 
protein synthesis (Kato et al., 1965; Conney, 1956) following augmented DNA-
dependent RNA synthesis (Gelboin et al., 1967; Wilson et al., 1967). However, 
alternate explanations may be considered since microsomal protein may 
accumulate independently of enhanced protein synthesis (Barnhard, 1969) through 
stabilization of pre-existing protein (Kenny, 1967; Rechcigl, Jr., 1968). This 
argument is strengthened by the observation that Pb treatment will stabilize 
liver microsomal enzyme protein (Shuster and Jick, 1966) and phospholipid 
(Orrenius and Ericsson, 1966; Holtzman and Gillette, 1966). 
5 
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Messenger RNA turnover rate has been suggested as a potential control 
site in protein synthesis (Tomkins et al., 1969; Lawford and Schachter, 1966) 
or hormone action (0 'Malley, 1969). Conceivably, increased messenger RNA 
availability for translation into enzyme protein may result from increased 
DNA-dependent RNA synthesis and or reduced messenger RNA degradation. 
Accordingly it may be postulated that enzyme inducers may increase liver 
microsomal protein content due to reduced protein or RNA degradation as 
well as via increased protein synthesis subsequent to enhanced RNA synthesis 
or both. 
This investigation was undertaken to examine the role of microsomal 
ribonuclease in the induction of microsomal drug-metabolizing enzymes by 
Pb and 3M C. Microsomal ribonuclease activity was examined during Pb 
induction in intact, adrenalectomized and hypophysectomized rats to determine 
whether intact adrenal or pituitary glands were required for suppression of 
ribonuclease activity. ~vitro e:x.--periments were designed to detect the 
presence of inhibitors of ribonuclease activity in livers of Pb-treated rats. 
The second investigation described herein examines the mechanism of 
action of one of the known inhibitors of drug metabolism(amphetamine) (Lal, 
et al., 1970). The advisability of amphetamine administration to antagonize 
barbiturate depression may be questioned due to the recent finding of several 
investigators (Lal, et al., 1970; Weiss and Laties, 1964; Rushton and 
Steinberg, 1963). Amphetamine administration results in inhibition of hexobar-
bital metabolism (Lal, et.al., 1970) and, as may be predicted, potentiation of 
barbiturate activity (Weiss and Laties, 1964; Rushton and Steinberg, 1963). 
This section describes kinetic studies which have been performed using in vitro 
systems in order to determine a mechanistic basis for the potentiation of bar-
biturate action by administered amphetamine. 
II. LITERATURE SURVEY 
Drug Metabolism 
The duration and intensity of drug action is, for many agents inversely 
proportional to the rate at which the therapeutic agent may be removed from 
the body. Since many drugs must be metabolized to inactive metabolites 
prior to excretion, drug metabolism and its alteration has become an im-
portant therapeutic and pharmacologic consideration which has attracted a 
considerable amount of research attention. Numerous studies have shov..n that 
the majority of drugs are metabolized by few reactions, and that the enzyme 
systems which catalyze this metabolism are present in the endoplasmic re-
ticulum of the liver (Claude, 1969). 
The term microsome refers to the isolated form of the endoplasmic 
reticulum when this cytoplasmic constituent is obtained by differential centri-
fugation (Claude, 1969). Microsomal enzymes obtained from mammalian 
livers, catalyze a number of oxidations of which the reactions of oxidative 
drug metabolism (N-dealkylation, 0-dealkylation, side chain oxidation, deamin-
ation and aromatic hydroxylation) are only a part (Greene, 1968). Early investi-
gations have established that the enzymic oxidative metabolism of drugs is carried 
out by enzymes located in the microsomal fraction of the liver while the system 
which generates required NADPH can be fotmd in the soluble fraction. Oxygen 
is also a necessary co-factor (Conney, 1967). 
The requirement for both NADPH and oxygen is consistent with the postulate 
(Conney, 1967) that NADPH provides reducing equivalents for reduction of 
cytochrome P-450 in liver microsomes. The reduced P-450 is thought to form 
an "active oxygen" complex and the oxygen in the complex is then transferred 
to the drug substrate (Conney, 1967). 
7 
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Stimulation of Drug Metabolism 
Effect of Inducing Agents ~ ProtE?in Synthesis. 
An inducing agent may be defined as a compound which enhances enzyme 
activity by increasing the concentration of enzyme protein~ Conney, 1967). 
Considerable evidence exists to support the hypothesis that enhancement of 
drug-metabolizing enzyme(DME) activity by phenobarbital(Pb) or 3-methyl-
cholanthrene(MC) is mediated through stimulation of protein synthesis. Ad-
ministration of Pb stimulates amino acid incorporation into liver microsomal 
protein in vivo (Kato, et al. , 196 5) and in vitro(Jondorf et al. , 1966; Kato, ~ !!:.!.: , 
1966). The stimulation of amino acid incorporation and increase in microsomal 
enzyme activity following MC or Pb administration may be prevented by admin-
istration of actinomycin-D (Gelboin and Blackburn, 1964; Orrenius, 1964) an 
inhibitor of transcription (Reich, ~al. , 1961). The administration of inhibitors 
of translation such as ethionine(Conney, 1960) or puromycin(Conney, 1963) will 
also prevent the induction of DME by either Pb or MC. 
Effect of Inducing Agents on Phopholipid. 
The importance of suppressed degradation in increasing the levels of 
microsomal protein and phospholipid during Pb induction is controversial. 
Pb treatment is reported to stimulate the rate of incorporation of inorganic 
phosphate into microsomal phospholipid(Ernster and Orrenius, 196 5; Orrenius 
~al., 196 5). These results may be an indication of increased synthesis of phos-
pholipid s which accumulate in livers of Pb-treated rats (Ernster and Orrenius, 
1965). Holtzman and Gillette(l966) have demonstrated, however, that increased 
liver microsomal phospholipid in Pb-treated rats results from inhibition of 
phospholipid degradation. Stein and Stein (1969) have arrive'd at similar con-
clusions after observing that Pb treatment results in the inhibition of acyl-
phosphohydrolase (EC. 3. 6.1. 7) activity without stimulation of choline or etha.n-
olamine incorporation into microsomal phospholipid. 
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Tsukada and Lieberman (1965) suggest that microsomal phospholipid may 
stabilize polyribosomes sine phospholipase (EC. 3. 1.1. 4) treatment of 
polyribosomes results in inhibition of in vitro amino acid incorporation and 
marked polyribosomal disaggregation. 
Effect of Inducing Agents on Microsomal Protein Degradation. 
It has been postulated that the accumulation of liver microsomal protein 
following Pb treatment results from both a decreased rate of breakdown and 
an increased rate of synthesis. In support of this hypothesis Shuster and 
Jick (1966) demonstrated that Pb treatment reduces the rate of loss of in-
corporated tritiated leucine radioactivity from microsomal protein, to 
one-half that observed in controls. In addition, no loss of radioactivity from 
purified pre-labeled mouse liver NADPH Cytochrome c reductase (EC. 1. 6. 99.1) 
was observed following Pb induction (Jick and Shuster, 1966) suggesting a 
complete lack of degradation of the enzymes. Enzyme stabilization in the 
presence of cycloheximide inhibited protein synthesis has been reported by 
Kenny {196 7). Loss of radioactivity from tyrosine-transaminase (E c. 2. 6. 1. 5) 
occurs at a slower rate in cycloheximide-treated rats relative to untreated 
controls. 
These findings are in contrast with those of Holtzman (1969) Schimke et al., 
(1968) and Arias et al., (1969) who have failed to demonstrate stabilization of 
microsomal protein by Pb in experiments utilizing 14c-guanidino-arginine, a 
non-reutilized amino acid. Shirnke and collaborators compared the effect of 
Pb on microsomal isotope retention using 14c-guanidino-arginine or tritiated 
leucine as labels. They were able to demonstrate decreased release of label 
when leucine was used to pre-label microsomal protein, follo>ving Pb treatment. 
However, when 14 C-guanidino-arginine was used no evidence of membrane 
protein stabilization by Pb could be demonstrated. The retention of 3H-leucine 
was attributed to an increased degree of isoto.pe reutilization in the Pb treated 
animal. However, T. Omura at a recent meeting of the International Symposium 
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on microsomes and drug oxidations, at Tubingen; as reported by Schenkman 
(1970) described studies indicating that14c-guanidino-arginine-labeled microsomal 
protein degradation is inhibited by Pb. 
Thus, it is evident that the precise role of microsomal protein degrada-
tion in the mediation of Pb induction of DME remains unclear. 
Other Post-Translational Mechanisms. 
Evidence exists to support a hypothesis that post-translational controls 
are operative during induction of microsomal DME systems. Reduction of 
levels of any rate-limiting component during induction will interfere with the 
enhancement of synthesis of metabolically active protein. 6 ·-Aminolevulinic 
acid synthetase induction by Pb was demonstrated by Marver (1969) who 
suggested this as a means of providing the additional heme required for 
increased synthesis of microsomal cytochromes. Administration of heme 
inhibits Pb induction of S -aminolevulinic acid synthethase and DME activity 
and interferes with development of tolerance to hexobarbital (Marver, 1969). 
3-Amino-1, 2, 4-triazole inhibits rat hepatic b -aminolevulinic acid dehydratase 
(EC. 4. 2.1. 24) which catalyzes the second step involved in heme biosynthesis 
(Baron and Tephly, 1969). These authors demonstrated that 3-amino-1,2, 4-
triazole inhibited Pb induction of cytochrome P-450 and inhibited Pb stimula-
tion of ethylmorphine, or 3-methyl, 4-monoethylaminobenzene metabolism 
(Baron and Tephly, 1969). However, no effect was observed on Pb stimulation 
of NADPH-cytochrome c reductase activity in animals pretreated with 3-amino-
1, 2, 4-triazole (Baron and Tephly, 1969). While these data suggest that post-
translational control of Pb induction may exist, the possibility that these in-
hibitors may interfere with other limiting factors required for induction of 
DME, has not been excluded at this time. 
Effec! of Inducing Agents on RNA Synthesis. 
The stimulation of hepatic protein synthesis by Pb or MG is postulated 
to involve enhancement of DNA-directed RNA synthesis. Administration of 
100 mg/kg of either Pb or MC stimulates nuclear RNA polymerase (as detei·mined 
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by incorporation of radioactive cytidine triphosphate into RNA) of isolated 
rat liver nuclei within 3-20 hours (Wilson, et al., 1967; Gelboin ~al., 1967; Nebert 
and Gelboin, 1969). MC stimulation of RNA polymerase (EC. 2. 7. 7. 6) 
of isolated rat liver nuclei is consistent with reported stimulation of orotic 
acid- 14c uptake into nuclear RNA 3 hours after injection of MC (Leob and 
Gelboin, 1964). Bresnick and Mosse (1969) have demonstrated that MC ad-
ministration results in increased template activity of nuclear chromatin. In 
these studies HNA synthesis was catalyzed by purified Micrococcus lyso-
deicticus RNA polymerase. Furthermore, nearest-neighbor frequency 
analyses of newly synthesized RNA indicate that this RNA is different from 
RNA synthesized from control preparations (Bresnick and Madix, 1969; 
Bresnick ~al., 1969). As previously mentioned, the administration of 
actinomycin-D prevents the stimulation of benzpyrene hydroxylase activity 
by MC (Gelboin and Blackburn, 1964). These data indicate that MC induces 
liver DME through genomic activation, resulting in increased DNA-dependent 
RNA synthesis followed by enhanced synthesis of DME. 
Different mechanisms may be involved during Pb induction. Chromatin 
isolated from Pb-treated rats directs synthesis of RNA with similar nearest-
neighbor frequencies to control preparations (Bresnick and Madix, 1969). 
Actinomycin-D in doses close to the LD50 (Philips~ al., 1960) inhibits but 
does not completely prevent stimulation of enzyme activity produced by five 
doses of Pb (Ernster and Orrenius, 1965; Orrcnius and Ernster, 1964). Three-
fold increases in DME activity are produced by Pb when actinomycin-D is 
given simultaneously for 5 days as opposed to 4. 2 fold increases in DME 
produced by Pb alone. 
Administration of an RNA polymerase inhibitor which has been char-
acterized by Wilson et al., (1967); Gelboin, (1966) viz., A1--:atoxin B1 , 
does not inhibit Pb induction of DME (Kato, et al., (1969). These authors 
have also demonstrated that Pb will induce tolerance to hexobarbital in the 
presence of aflatm ... "in B1. 
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Thioacetamide is a carcinogen which increases nuclear size (Nluramatsu 
and Busch, 1962) and produces ·marked (8-10 fold) increases in latent nuclear 
ribonuclease activity and reduces cytoplasmic RNA content (Villabos ~al., 
1964; 1965; Busch, 1965). Thioacetamide prevents the increases in micro-
somal N-demethylase and cytochrome P-450 content usually associated with 
Pb induction, however, thioacetamide has little effect on the enhancement of 
drug metabolism resulting from MC administration (Sladek and Mannering, 
1969; Mannering et al., 1969). 
Enhancement of RNA polymerase has been reported in Pb treated 
adrenalectomized rats but not Pb treated hypophysectomized rats (Nebert and 
Gelboin, 1969; Wilson et al., 1967). However, it is well-established that Pb-
stimulation of microsomal amino acid incorporation (Jondorf et_&., 1966) and 
induction of DME by Pb is not abolished by hypophysectomy (Conney, 1961). 
Thus, in hypophysectomized rats, Pb-stimulation of RNA polymerase does 
not appear to. play a major role in the induction of Dl\IE. 
Evidence for Role of Ribonuclease. 
Several investigators (Tomkins et al., 1969; Bresnick, 1967; O'Malley, 
1969) have postulated that messenger RNA stabilization might be involved in 
enzyme induction. Control of RNA lifetime by RNase could conceivably operate 
as a key factor in control of protein synthesis (Barnard, 1969). 
Distribution studies of rat liver ribonuclease (RJ.'{ase) indicate that RNase 
is widely distributed among particulate and non-particulate subcellular fractions 
(De Duve, 1955; Rahman, 1967). Approximately 26-50 percent of total cellular 
RNase is found in rat liver microsomal and soluble fractions. Rat liver ribo-
nuclease activity components may be characterized by pH optima as follows: 
pH 6. 0 (RNase I), pH 7. 8 (RNase II), (Roth, 1954) and, pH 9. 5 (RNase III) 
(Rahman, 1967). Acid RNase (RNase I) is localized in the lysosomal fraction 
along with other acid hydrolases while alkaline RNase has a somewhat wider 
distribution and is potentially in close contact with R:N"A (Kraft~ al., 1969). 
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An inverse relationship between RNase activity and RNA synthesis has 
been suggested by the finding of several workers. Reduced incorporation of 
label into RNA occurs in the presence of increased RNase activity (Meisler 
and Tropp, 1969). These authors also demonstrated that stimulation of in 
vitro RNA synthesis by deoxycholate or ammonium sulfate was correlated 
with inhibition of nuclear RNase. Similarly, Wilson et al. , (1967) demonstrated 
that in the presence of added RNase negligible RNA polymerase activity 
(determined by cytidine-3n triphosphate incorporation into RNA) is observed. 
Further, Sarkar (1969), using a system induced by pretreatment with Tri-
amcinolone observed an inverse correlation between liver RNase activity and 
RNA content. 
Increased RNase activity in vitro has been shown to inhibit 14c-leucine 
incorporation into rat liver microsomes (Sto~e and Joshi, 1962). Addition of 
RNase to bacterial cell-free protein synthesizing systems inhibits 14c-phenyl-
alanine incor.poration into ribosomal protein by 99% (Scheinbuks ~al., 1969). 
Inhibition of in vitro protein synthesis by RNase appears to be due to 
increased degradation of messenger RNA followed by polysomal disaggregation. 
Barondes and Nirenberg (1962) and Igarashi (1969) have reported that added 
synthetic messenger can be rapidly degraded in cell-free protein synthesizing 
systems before significant polymerization of amino acids can be detected. 
Blobel and Potter (1966) have postulated that polysomal structure is highly 
sensitive to RNase since exposed interribosomal messenger RNA segments 
are more readily available for digestion by RNase than are protein-protected 
ribosomal RNA. Utsunomiya and Roth (1966) compared relative stabilities of 
ribosomal and non-ribosomal RNA by determining the origin of acid-soluble 
RNA degradation products in incubation media containing non-ribosomal RNA 
and 32P-labeled ribosomes. These authors demonstrated that ribosomal RNA 
was not significantly degraded to acid soluble products by RNase associated 
with ribosomal particles. 
Recent findings of Schlaeger et al. (1969) are in contrast with earlier 
studies which suggested an inverse relationship between polyribosome stability 
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and RNase activity. Schlaeger and collaborators treated tumor cells with 
2, 3, 5-tris (ethylene imino)-1, 4-benzoquinone (trenimon) to induce RNase 
activity and were unable to demonstrate any reduction in stability of poly-
somes isolated from tumor cells as cellular RN ase activity as increased. 
However, these authors failed to demonstrate that the polyribosomes isolated 
from treinimon-treated cells were actually capable of supporting protein 
synthesis or that RNase associated with polyribosomes isolated from teinimon-
treated cells actually contained increased RNase activities. 
In vitro recombination studies comparing amino acid-incorporating 
activity of cell-free systems derived from rat or chicken livers have demon-
strated that chicken liver cell sap contains markedly elevated levels of RNase 
activity (Siler and Fied, 1968). These studies have shown that incubation of 
rat liver microsomes with chicken cell sap r~sults in marked inhibition of 
polyuridylic acid-directed phenylalanine incorporation related to increased 
degradation of polyuridylic acid. Conversely, incubation of chicken liver 
microsomes with rat liver cell sap results in amino acid incorporation which 
is equivalent to that observed in incubations of rat supernatant and rat micro-
somes. These findings are consistant with those of Roth (1962) who has re-
ported that an endogenous RNase inhibitor which is found in livers of rats, 
mice and hamsters, is absent in chicken liver. It is reasonable to conclude 
that the diminished protein synthetic ability of chicken liver microsomes 
associated with increased RNase activity is a function of messenger RNA 
destruction. Thus, the presence of high RNase activity would be expected to 
decrease the response of an inducing agent which stimulates enzyme synthesis. 
It has been demonstrated that while nikethimide induction of rats produces 
tolerance to pentobarbital, nikethimide pretreatment of chickens does not reduce 
the effect of subsequent pentobarbital treatment (Brazda ~al., 1965). DDT reduces 
dieldrin storage in the rat but not in the chicken (Street et al., 1966). These 
results are consistent with the concept that induction of DME is more difficult 
in the presence of marked increases in RNase activity. 
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Modification of RNA Degradation During Enzyme Induction. 
Administration of 14c-indoleacet~c acid to green pea stem segments 
results in initiation of growth and increased labeling of RNA (Bedana and 
Galston, 1965), RNA fractions extracted from treated stem segments are 
more resistant to RNA degradation than those extracted from untreated 
control preparations. During cortisone induction an inverse relationship 
has been demonstrated (Barnabei and Ottolenghi, 1968) between activity of 
rat liver microsomal RNase and RNA polymerase. A similar inverse 
relationship between RNA polymerase and microsomal RNase after cortisone 
treatment has been reported (Terner et al., 1967). Sarkar et al., (1969) have 
demonstrated a reduction of rat liver acid (EC. 2. 7. 7 .16) and alkaline RNase 
(EC. 2. 7. 7.17) activity during triamcinolone treatment which could be correlated 
with increases in aspartate and alanine aminotransferase activities. 
Hormones have been shown to alter tissue RNase activity. Augmented 
RNA levels have been correlated with decreased adrenal RNase following 
corticotrophin administration to rats. This suppression of adrenal RNase 
activity could be correlated with increased amounts of RNase inhibitor 
(Imrie and Hutchison, 196 5). Brewer et al., (1969) reported two-fold in-
creases in alkaline RN ase in postmitochondrial supernatant fractions prepared 
from hypophysectomized rats. They also reported that administration of 
growth hormone resulted in the reduction of RNase activity to control levels. 
The half-life of deoxythymidine kinase messenger RNA is doubled in 
regenerating rat liver compared to controls (Bresnick, et al., 1967). These 
authors postulate that hepatectomy results the elaboration of a substance which 
prolongs mRNA half-life by inactivating RNA catabolism. Inhibition of RNA 
degradation in regenerating liver may be attributable to increased amounts of 
endogenous RNase inhibitors which accumulate in regenerating rat liver 
(Russell and Snyder, 1969; Tsukada, 1969; Shortman, 1962). 
Thus much experimental evidence suggest that RNA levels and protein 
16 
synthesis are influenced by RNase activity. Altered RNA degradation appears 
to be part of the total cellular response to certain drugs and hormones as well 
as ·experimental procedures which result in or otherwise affect induction of 
enzyme protein. 
Physiological Control of Ribonuclease Activity; Mechanisms. 
Several potential control mechanisms have been implicated in the 
literature or otherwise indicated as physiological control mechanisms of RNA 
degradation. The more obvious among these are: 
A) Compartmentation of enzyme (or subtrate) such as occurs with lysosomal 
concentration of acid RNase (Kraft, et al., 1969). 
B) Endogenous inhibitors of RNase such as cations (Lamana and Mallette, 
1949) polyamines (Busch, 1965) or protein RNase inhibitors (Gribnau 
et al., 1970; Roth, 1962; Shortman, 1961; 1962). 
C) Steric inaccesibility ofRNA to degradation by RNase e.g. ribosomal RNA 
protection (Utsunomiya and Roth, 1966) (Castle and Singer, 1965). 
D) Combination of hormone with RNA resulting in stabilization of hormone-
RNA complex (Bedana and Galston, 196 5) or prevention of ribosomal 
attachment to RNA resulting in enhancement of RNA degradation (Tomkins 
et al., 1969). 
Inhibition of Drug Metabolism 
The clinical administration of amphetamine in cases of barbiturate 
poisoning is based on tre expected antagonism of barbiturate activity by this 
stimulant. However, recent findings that amphetamine will potentiate bar-
bi.turate activity in certain instances suggest that this practice may be ill-
advised. 
Rushton and Steinberg (1963) have demonstrated that simultaneous ad-
ministration of "amobarbitone and d-amphetamine resulted in potentiation of 
the effects of "amobarbitone" on rat motor activity. Weiss and Laties (1964) 
demonstrated that combinations of pentobarbital. and amphetamine potentiated 
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pentobarbital effects on dog behavioral activity. Such potentiation of 
barbiturate activity may be attributable to amphetamine interference 
with barbiturate biotransformation. Reports of interference with drug 
metabolism involving amphetamine and methylphenidate (a related phene-
thylamine derivative) have appeared in the recent literature. 
Methylphenidate inhibits imipramine metabolism in mouse liver where 
imipramine hydroxylation predominates and in rat liver where demethylation 
is themajor route of imipramine biotransformation (Perel et~·, 1969). 
Similarly, d-amphetamine metabolism which presumably involves p-hydroxy-
lation (Axelrod, 1954) by perfused rat liver, is inhibited by desipramine 
(Dingel and Bass, 1969). Lal et al., (1970) have demonstrated that amphetamine 
inhibits mouse liver hexobarbital oxidase following in vivo administration or 
in vitro addition of amphetamine to incubation mixtures. These results appear 
to contrast with those of Kato et al., (1964); Kato and Chiesara (1962) and 
Kato and Vassanelli (1962) who failed to demonstrate any effect cf amphetamine 
administration on the response of rats to subsequent administration of mepro-
bamate or"phenobarbitone." However, Kato and collaborators pretreated rats 
with amphetamine 48 hours prior to testing while Lal and co-workers administered 
amphetamine 1 hour before testing. 
Inhibition of drug-metabolism occurs competitively in the presence of 
alternative substrates of microsomal DME (Rubin et al., 1964). It is reasonable 
to expect that since amphetamine is para hydroxylated by the rat in vivo 
(Axelrod, 1954), amphetamine inhibition of drug metabolism may be attributed 
to competition by an alternative substrate. However, d-amphetamine is not 
metabolized by rat liver microsomes (Groppetti and Costa, 1965) or rat liver 
10, 000 x g supernatant fractions (Dingel and Bass, 1969). These findings 
suggest that an investigation of the kinetics of amphetamine inhibition of drug 
metabolism by liver supernatant fraction may contribute to a better under-
standing of the mechanisms involved in similar drug-drug interactions. 
III. EXPERilv1ENTAL 
Animals 
Male and female Sprague-Dawley rats obtained from Charles River 
Breeding Laboratories (Wilmington, Mass.) weighing between O. 1-0. 5 kg 
were used throughout the course of these studies. The rats were maintained 
on commercial laboratory chow and water ad libitum in a room with controlled 
temperature and alternating 12-hour periods of light and darkness. All drugs 
were administered via the intraperitoneal route. Adrenalectomies and Hypo-
physectomies were performed by Charles River Breeding Laboratories. 
Materials 
Analytical reagent grade chemicals or equivalent were used throughout 
these studies. Cofactors (NADP, glucose-6-phosphate, p-chloroaniline , p-
chloro-N-:methylaniline, glucose-6-phosphate dehydrogenase (EC #1.1.1. 49) 
and highly polymerized yeast RNA) were obtained from Calbiochem. Los Angeles, . 
Calif. and crystalline bovine serum albumin was obtained from Armour Lab-
oratories. Drugs used were obtained from their respective manufacturers. 
Preparation C1f Rat Liver Supernatant Fractions For Kinetic Studies. 
Femafo {250-300 gm) and Male (325-348 gm) rats were decapitated. 
Livers were perfused with ice-cold 0.15M KCl and were homogenized in 2 vol. 
of ice-cold O. lM phosphate (pH7. 4) buffer for 1 min in a coaxial homogenizer. 
The 9000 x g supernatant fraction was obtained by centrifugation at o0 c (10, 000 
rpm in an Model B-60 International Preparative Ultracentrifuge (I.E. C.) #874 
rotor) for 30 min. 
Preparation .of Rat Liver Supernatant Fractions. 
Adult male rats were fuillotined following overnight fast. Their livers were 
perfused in situ with ice-cold 0. 251\1 sucrose and were homogenized with a 
coaxial homogenizer at 1000 RPM for one minute with 3-5 volumes of ice-cold 
0. 25M sucrose. Homogenates were centrifuged at 14, 000 x g for 15 min at 
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o0 c in I.E. C. preparative ultracentrifuge and the resulting supernatant was 
centrifuged at 105, 000 x g for 2 hours at o0 c. The 105, 000 x g pellet was 
rinsed and dispersed in 0.25M sucrose and stored at -20°c until assayed. 
Analytical Procedures 
Determination of Microsomal Demethylation '2! Aminopyrine. 
Microsomal demethylation of aminopyrine was determined by assaying 
for formaldehyde formed as described by McMahon and Easton (1962). The 
incubation medium (5 ml) for aminopyrine demethylation contained aminopyrine 
10 µMoles, NADP 2 µMoles, Mg Cl2 50 µMoles, 0. 8 ml 105, 000 x g super-
natant from control animals, O. 2 ml microsomal suspension (approximately 
6 mg protein) and 1 ml 0.1 M phosphate buffer pH 7. 4. Parallel incubation 
flasks containing 1. 32 µMoles of formaldehyde (standard) in place of substrate 
and distilled water (blank) in place of substrate were carried through the entire 
procedure. Flasks were incubated in a Dubnoff shaker at. 37°C under air for 
30 m,in. At the end of the incubation perioo flask contents were poured into 
centrifuge tubes. Four ml of 10% zinc chloride (prepared with co2-frce water) 
were .added and the tubes were mixed. Two ml of a saturated solution of barium 
hydroxide were added and the samples were mixed again. The samples were 
centrifuged for approximately 10 min and 5. 0 ml aliquots of clear supernates 
were transferred to glass tubes containing 2. 0 ml of double-strength Nash 
reagent (0. 04 M acetylacetone in 0. 4 M ammonium acetate-0. l M acetic acid). 
The contents were mixed and the tubes were heated in a water bath at 60°c for 
30 min. Absorbance was determined on a Beckman DB-G grating spectrophoto-
meter at 410 rnµ, and the values were corrected for color of the blank. Amount 
of formaldehyde formed was determined by comparison with absorbance of 
standards . 
Determination of P-Chloro-N-Methylaniline Demethylation. 
Demethylation of p-chloro-N -methylaniline (PCMA) was determined 
by assaying for p-chloroaniline formed according to the procedure of Kupfer 
and Bruggeman (1966) as modified by Fuller et al., (1969). Incubations 
were carried out at 37° C under air for 30 min in m edia which contained 
3 µ.Moles PCMA, 1. 6 µ.Moles NADP, 16 µ.Moles glucose-6-phosphate, 
30 µ.Moles Mg Cl2 , 20 µ.Moles nicotinamide, 5 IU glucose-6-phosphate 
dehydrogenase, 120 µ.Moles phosphate buffer (pH 7. 4) and 14, 00 x g rat 
liver supernatant (2-4 mg) protein. The reaction was stoppe d by the 
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addition of 3. 0 ml p-dimethylaminobenzaldehyde (20 mg/ml lN H2so 4) 
solution. Incubation fl.ask contents were mixed and centrifuged at 8000 x g 
for 30 min. Colors read on a Beckman DB-G grating spectrophotometer at 
445 mµ. were corrected for color of blanks. Amount of p-chloroaniline formed 
was determined by comparison with standards. 
For kinetic studies PCMA demethylation was determined as described 
above with the following modifications. Incubations were carried out at 37°C 
~nder air in media containing 0. 2 ml 9000 x g supernatant protein (6. 6-7. 4 mg 
protein) equivalent to approximately 100 mg liver; 1. 6 µ.Moles NADP, 16 µ.Moles 
glucose-6-phosphate, 30 µ.Moles MgC12 , 20 µ.Moles nicotinamide, 150 µ.Moles 
phosphate buffer (pH 7. 4) and PCMA (6, 4, 5, 3 or 1. 5 µ.Moles) in a total volume 
of 2 ml. Six µ.Moles d-amphetamine sulfate was used. 
· Determination of Phenolpthalein-~-Glucuronidase Activity. 
Phenolpthalein-{J-glucuronidase activity associated with microsomal 
fractions was determined by assaying for phenolpthalein formed from phenol-
pthalein glucuronide according to the procedure of Talalay et al. (1946). 
Incubations were carried out in a dubnoff shaker for 15 min at 37° C. Incuba-
tion media contained 5 µ.l microsomal suspension (0. 2 mg protein). 0. 5 ml 
phenolpthalein-{J-glucuronide (2 mg/ml in O. 2 M acetate buffer (pH 5. 2) 
solution, 0. 5 ml deionized water, 4. 0 ml O. 2 M pH 5. 2 acetate buffer. Parallel 
incubations containing 50 µ.g phenolpthalein (standard) in place of substrate and 
distilled water (blank) in place of substrate were carried through the entire pro-
cedure. 
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At the end of the incubation period 5. 0 ml 4M glycine (adjusted to pH 
10. 7 with NaOH) was added to the fl.asks and the contents were centrifuged 
for 15 min in a clinical centrifuge. Absorbances read on a Beckman DB-G 
grating spectrophotometer at 545 mµ were corrected for color of blanks. 
The amount of phenolpthalein formed was determined by comparison with 
the standard. 
Determination of P-Nitroanisole Demethylase Activity. 
P-Nitroanisole demethylase activity associated with microsomal fractions 
was determined by assaying for p-nitrophenol formed according to a modifica-
tion of the procedure of Netter and Seidel (1964). Incubations were carried 
out at 37° C under air for 30 min in a medium containing 3 µMoles p-nitroanisole, 
2 µMoles NADP, 20 µMoles glucose-6-phosphate, 80 µMoles nicotinamide, 
120 µMoles Mg c12 , 5 IU glucose-6-phosphate dehydrogenase microsomal pro-
tein (2-3 mg) and 1 ml 0.1 molar phosphate (pH 7. 9) buffer in a total volume 
of 3. 9 ml. 
At the end of the incubation period 10 ml ice-cold acetone was added to 
the incubation flasks. One ml 0. 5 M glycine (adjusted to pH 9. 5 with NaOH) 
was added. After centrifugation the supernatant was read a,gainst the tissue 
blank at 410 mµ on a Beckman DB-G grating spectrophotometer. Amount of 
p-nitrophenol formed was determined by comparison .with standard p-nitrophenol 
solutions. 
Determination of Ribonuclease Activity. 
Ribonuclease activity of microsomal fractions was determined by assaying 
for the acid-ethanol-soluble degradation products of highly· polymerized RNA, 
according to a modification of the procedure of Tsukada (1969). Incubations 
were carried out at ·37°c under air for 20 min in a medium containing 0.2 ml 
O. 2 M Tris-HCl buffer pH 7. 6, 1 mg highly polymerized yeast RNA and micro-
somal protein (0. 5-1 mg). At the end of the incubation period 1. 0 ni lM HCl 
in 76% ethanol was added as a precipitant and the mixture was shaken thoroughly. 
22 
The soluble fraction was separated by centrifugation at 10, 000 RPM at o0 c 
in the #874 rotor of the I.E. C. preparative ultracentrifuge for 15 min. The 
absorbance of 1 ml of the clear supernatant after dilution with 2-5 ml distilled 
water was read at 260 mµ vs distilled water using a Beckman DB-G grating 
spectrophotometer. Readings obtained were corrected for absorbances of 
individual tissue and RNA blanks. 
Estimation of Protein 
Protein content was determined by the colorimetric procedure of Lowry 
et al., (1951) with minor modifications. An aliquot (0.1 ml) of microsomal 
suspension was added to 15 ml test tubes containing 10 ml of 0. 5 M sodium 
hydroxide . The tubes were heated in a water bath until dissolution was complete. 
Standard solutions of crystalline bovine serum albumin and a blank consisting 
of 0. 2 5 M sucrose were carried through the entire procedure. When the tissue 
was dissolved a O. 5 ml aliquot was removed and placed into a second tube con-
taining 1 ml of O. 5M sodium hydroxide solution. Five ml of reagent 'A' (pre-
pared by the addition of 1. 0 ml 1 % cupric sulfate solution plus 1. 0 ml of 2. 7% 
potassium tartrate to 100 ml of 2% sodium carbonate solution) was added to 
each tube, mixed, and the tubes were allowed to stand at room temperature 
for 20 min. At this time 0. 5 ml reagent 'B' (prepared by diluting commercial 
Folin-phenol reagent vvith an equal volume of distilled water) was added to each 
sample. The samples were allowed to stand at room temperature for 40 min to 
develop color. Absorbance at 500 mµ of the solutions was determined against 
the blank in a Beckman DB-G grating spectrophotometer. 
Statistical Methods 
The students' "t" test calculated on an Olivetti Underwood Programma 
101 was used to test for differences between means throughout this study. The 
formula employed is as follows: 
Nl = 
N2 = 
s1 2 = 
t = 
where: 
s 2 = 
p 
Control sample size 
Treated sample size 
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N1 + N2 - 2 
s2 
2 
= Treated sample variance 
x1 = Control sample mean 
Control sample variance ~ Treated sample mean 
The degrees of freedom were taken as N1 + N2 - 2 
The levels of P: were taken from Appendix 3 (Spiegel, 1961) 
Calculation of Kinetic Constants 
The data obtained from kinetic studies was statistically analyzed using 
an IBM linear regression computer program entitled 'Boing'. The formula 
used is as follows: 
y A0 + AiX 
( ~ Y) ( ~ x2) - ( ~ X) ( 5" XY) 
N £ XY - ( ~X) ('LY) 
where: 
Xand Y = the reciprocals of the substrate concentration and 
velocities respectively. 
N = number of substrate concentrations employed. 
y = 1/observed velocity (or 1/µMoles of p-chloroaniline/ 
min/mg protein). 
Ai = Km/V (where Km is the Michaelis constant and 
V Tsanie maximum velocity). 
max 
x 1/substrate concentration (or 1/mMolar p-chloro-N-
methylaniline concentration. 
Ao = !/maximum velocity (or 1/V ). max 
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The inhibition constant (Ki} was calculated on the basis that the slope of a 
double reciprocal (1/v vs. 1/s) plot is altered by the factor (1 + i/Ki) in 
the presence of a competitive inhibitor (Mahler and Cordes, 1966). 
where i 




was given to controls. The animals were killed on day 5 and liver microsomal 
fractions prepared from these animals were assayed for aminopyrine de-
methylase and RNase activity. 
The effects of two doses of Pb (50 mg/kg and 2 5 mg/kg twice daily 
for 4 days) on microsomal aminopyrine demethylase and RNase of intact adrenal-
ectomized and hypophysectomized rats were qualitatively similar (Table 2). 
In all groups except one, Pb significantly increased aminopyrine demethyla-
tion and reduced microsomal RNase activity. In each experiment, Pb treat-
ment of hypophysectomized and adrenalectomized rats resulted in less 
stimulation of aminopyrine demethylation or inhibition of RNase than that 
observed in intact rats. An inverse correlation between the Pb stimulation 
of aminopyrine demethylation and inhibition of microsomal RNase was 
observed in all experiments. 
In order to determine whether the observed differences in ribonuclease 
were due to differences in the degree of lysosomal contamination, liver micro-
somal fractiorn from Pb-treated (50 mg/kg 5 days) and control animals were 
assayed for ,B-glucuronidase activity which is localized in the lysosomal 
fraction of rat liver (DeDUve, 1955).Phenolpthalein-,B-glucuronidase activity of 
microsomal fractions obtained from Pb-treated animals was not significantly 
(P >0. 05) different from controls thereby indicating that differential lysosomal 
contamination was not a factor in the reduction of RNase activity of Pb-treated-
rat microsomes (Table 3). 
Since differences (described earlier in this thesis) exist between the 
characteristics of MC and Pb induction of DME, the following experiment .was 
designed to determine the effect of MC induction on RNase activity of microsomal 
fractions. MC (40 mg/kg) was administered to male rats for two days. 
Controls received the vehicle (corn oil). The animals were killed on the 
third day and microsomal fractions prepared from these animals were 
assayed for p-nitroanisole demethylase and RNase activity. 
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Table 2 
Inhibition of Ribonuclease During Phenobarbital Induction of 
Microsomal Hepatic Drug-Metabolism in Intact. Adrenalecto-
mized and Hypophysectomized Male Ratsa 
Aminopyrine Liver Microsomal 
demethylaseb Ribonuclease c Protein mg/ gm 
Treatment (N) Mean :!: S. E. Mean + S. E. liver ~ S. E. (N) 
INTACT RATS 
Control (6) + 59. 8 - 2. 9 o. 230 ~ o. 027 + 21.0-0.82 
Phenobarbital 
25 mg/kg (5) + d 91.2 - 4.7 + d o. 105 - o. 021 27.1~2.9 
Phenobarbital 
50 mg/kg (6) + d 100. 5 - 2. 9 + d o. 068 - o. 008 + d 28.1 - 1. 4 
ADRENALECTOMIZED 
Control (6) 50. 2 ~ 1. 9 + . 0.161 - 0. 019 19. 9 ~ 0. 9 
Phenobarbital 
+ d 25 mg/kg (5) 0.114 ~ 0. 020NS + d 65. 4 - 2. 5 24.0_l.7 
Phenobarbital 
50 mg/kg (11) + d 69.9-3.0 o. 102 ~ o. 01od + 26.0_l.1 
HYPOPHYSECTOMIZED 
Control (6) + 48. 0 - 1. 3 0. 364 ~ o. 050 15.7~1.3 
Phenobarbital 
25 mg/kg (5) + d 68. 6 - 2. 5 + d 0.150 - o. 014 4 + d 2 .1 - 1.9 
Phenobarbital 
50 mg/kg (8) 68.7±5.od 0.147 :!: o. 050d 26.2~1.4d 
aForty-five day old intact (170-200 gm), adrenalectomized (150-200 gm) and 
hypophysectomized (100-120 gm) male rats received phenobarbital twice 
daily for 4 days and were sacrificed on day 5. Adr-enalectomized and Hypop-
hysectomized rats were used 2 weeks after operations. 
bExpressed as mµMoles formaldehyde formed/30 min/mg microsomal protein. 
CExpressed as optical density units at 260 mµ/20 min/mg microsomal protein. 
dsignificantly different from respective controls <™· 05). 
NSNot significantly different from control (p > O. 05) 
Control 
Table 3 
Phenolpthalein-{3-Glucuronidase Activity of Microsomal 
Fractions Obtained from Livers of Normal and Phenobarbital-
Treated Ratsa 
{3-Glucuronidaseb 
Mean :!:" S. E. (N) 
Phenobarbital 
43. 2 ~ 1. 2 (5) 
46.0 ~ 4.7c (4) 
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aValues represent means ~ standard error of determinations from controls 
and rats (375-410 gm) treated with phe~obarbital (50 mg/kg) for 5 days. 
bExpressed as mµMoles phenolpthalein formed/mg protein/15 min. 
cNot significantly different from control (P ~ O. 05). 
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Two-day MC treatment (40 mg/kg) resulted in a significant (P~ O. 05) 
three-fold stimulation of microsomal p-nitroanisole demethylation one day 
after termination of treatment (Table 4). However, this three-fold stimulation 
of microsomal p-nitroanisole demethylation is associated with a non-sig-
nificant (P>O. 05) inhibition of RNase activity with this inducing agent. 
In Vitro Recombination Studies. 
Microsomes and 105, 000 x g supernatant fractions obtained from control 
and Pb-treated rats were recombined to determine the presence of any endo-
genous inhibitors of RNase (Table 5 and Table 6). Negligible RNase activity 
was found in supernatants from either control of Pb-treated animals. In-
cubation of control supernatants with microsomes from Pb-treated rats 
resulted in a 17 percent stimulation of RNase activity. Conversely, when mi-
crosomes from untreated animals were incubated with supernatants from 
Pb-treated animals, control microsomal RNase activity was inhibited by 30 
percent and 87 percent of control values in the two experiments (Table 5, 
Table 6). 
Repetition of these experiments in the presence of p-chloromercuri-
-6 benzoate (10 M) which is reported to inactivate the rat liver RNase inhibitor 
characterized by Shortman (1962) resulted in 33-132 percent stimulation of 
RNase in the incubation mixture composed of microsomes and supernates 
prepared from Pb-treated animals (Table 6). In the incubation mixture 
composed of PCMB, control supernatant and control microsomal prepara-
tions 26 percent inhibition of RNase activity as observed. Addition of p-
chloromercuribenzoate to control microsomes incubated in the presence of 
Pb supernatant increased RNase by 13 percent but not to control levels. 
Boiled 105, 000 x g supernatant from Pb-treated rats were still able to inhibit 
RNase activity of control microsomes. 
In vitro addition of concentrations of Pb as high as 1 x 10.- 2 molar did 
not influence RNase activity of microsomal fractions. Caffeine, barbital 
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Table 4 
Comparison of Effect of Induction by 3-Methylcholanthrene on 





(40 mg/kg, 2 days) (5) 
P-Nitroanisole 
Demethylasea 
Mean ~ S. E. 
3. 46 ~ 1. 52 
+ c 13. 77 - 3. 52 
Ribonucleaseb 
Mean : S. E. 
o. 302 : 0. 038 
+ d 0.233 - 0.064 
aExpressed as mµMoles p-nitrophenol formed/mg microsomal protein/ 
30 min. (male rats 190-280 gms). 
bExpressed as optical density units at 260 rnµ/mg microsomal protein/20 min. 
csignificantly different from control (PCo~ 05). 
dNot significantly different from control (P~. 05)· 
Table 5 
In Vitro Inhibition of Microsomal Ribonuclease by 
105, 000 x g Liver Supernatant Fraction of the 




Control Control 0.370 
Phenobarbital Phenobarbital 0.160 
Control Phenobarbital 0.258 
Phenobarbital Control 0.187 
aone group of male (375-410 gm) rats was treated with 50 mg/kg 
phenobarbital for 5 days. All animals were killed 24 hours after the 
last treatment. Microsomes and supernatants used were obtained 
from one control and one Pb-treated rat. 
32 
· bExpressed as optical density units at 260 mµ/20 min/mg microsomal protein. 
Table 6 
Ribonuclease Inhibition in the Presence of P-Chloro-
mercuribenzoate by 105, 000 x g Supernatant Fraction 
Prepared from Livers of Phenobarbital-Treateda Rats. 
Microsomes b b Supernatant PCMBc Ribonuclease 
Control 0.151 
Phenobarbital o. 057 
Control + 0.120 
Phenobarbital + 0.016 
Control Control 0.231 
Control Control + 0.144 
Phenobarbital Phenobarbital 0.123 
Phenobarbital Phenobarbital + 0.164 
Control Phenobarbital 0.031 
Control Phenobarbital + 0.072 
Phenobarbital Control 0.159 
Phenobarbital Control + 0.139 
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e 
aFour male (375-410 gm) rats were treated with 50 mg/kg phenobarbital. for 
5 days. Controls were given distilled water. All animals were killed 24 
hours after the last treatment. 
~icrosomes and supernatants used were pooled from liver fractions pre-
pared from at least four animals. 
-6 
cp-Chloromercuribenzoate (10 molar). . 
~ean of duplicate determinations (Optical Density 260 mµ, /2 0 min/mg micro-
somal protein). 
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1 x 10-4 molar and dibutryl cyclic amp _1 x 10-6 molar did not alter RNase 
activity when added to the incubation medium. 
In order to isolate the inhibitor material, 105, 000 x g supernatant 
fractions prepared from Pb-trea ted and control rat livers were fractionated 
by 1Sephadex1 column chromatography. Prior to column fractionation both 
preparations contained negligible activity. In both preparations, fractions 
eluted at void volumes of the' Sephadex' column were found to contain RNase 
activity, while fractions eluted after void volume possessed RNase inhibitor 
activity. However, no differences in the elution profiles or in RNase activity 
stimulation or inhibition was observed between the two preparations. These 
results suggested that the RNase inhibitor in preparations from Pb-treated 
rats was inactivated or bound to the 'Sephadex' gel. 
Amphetamine Inhibition of P-Chloro-N-Methylaniline (PCMA) Demethylation. 
In order to determine the effect of d-amphetamine on PCMA demethylation, 
parallel incubations were carried out in the presence and absence of 3 x 10 - 3 
molar d-a.mphetamine sulfate. Data plotted in Figure 1 indicate that d-amphet-
amine sulfate inhibits PCMA demethylation competitively in liver preparations 
from 'male and female rats. Kinetic constants presented in Table 1 indicate 
that the apparent Km for PCMA demethylase activity of female rat liver is 
approximately 2 times that for male liver. Conversely, the maximum velocity 
of the female preparation is approximately two-thirds the corresponding value 
for the male rat liver enzyme. D-amphetamine sulfate increased the apparent 
Km of both preparations two-fold, while V is virtually unchanged. In-
max 
hibition constants for the two preparations are similar i.e., 2. 5 and 2. 7xlo-\.rolar 
for the male and female rat liver preparations respectiv~ly. 
Amphetamine inhibited PCMA demethylation when 8 x 10-3 molar NADPH 
was substituted for the NADPH-generating system. No differences in apparent 
p-chloroaniline formation by boiled supernatants were observed in the presence 
or absence of amphetamine in the incubation mixture. These results suggested 
that amphetamine inhibition was not due to either interference with the 
NADPH-generating system or development of color. 
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Fig. 2. Lineweaver-Burk plot of p-chloro-N-methylaniline demethyla-
tion by male and female rat liver 9000 x g supernatant in the 
presence and absence of 3 mMolar d-amphetamine sulfate. 
PCMA = p-chloro-N-methylaniline; PCA .. = p-chloroaniline. 
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Table 7 
Kinetic constants for D-Amphetamine Sulfate Inhibition of 
P-Chloro-N-Methylaniline Demethylation by Rat Liver 
9000 x g Supernatant Fractions. 
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Kinetic Constants Control Amphetamine 














0.25 o. 54 
2.5 2.4 
2.5 
0.49 1. 0 
1. 7 1. 8 
2.7 
aExpressed as mMolar p-chloro-N-methylaniline concentration. 
hExpressed as mµMoles p-chloroaniline formed/min/mg protein. 
cExpressed as mMolar d-amphetamine sulfate concentration. 
dKinetic constants were calculated from slope and intercepts determined 
according to the method of least squares. 
DISCUSSION 
Inhibition of Microsom al Ribonuclease During Phenobarbital Induction. 
Previous investigations have reported that Pb induction of DME is 
associate d with increased liver protein and enhancement of RNA synthesis. 
These findings are con.sistent with the observed suppression of RNase activity 
by microsomal preparations from Pb-treated rats. Conversely, three-fold 
stimulation of DME by MC treatment does not significantly reduce microsomal 
RNase. The findings reported here are consistent with earlier published 
data which suggest that Pb and MC induce DME through different mechanisms. 
The suppression of microsomal RNase reported here, when combined 
with previously documented enhanced activity of nuclear RNA polymerase, 
provide a mechanism to explain the increased amount of microsomal RNA, 
protein (Orrenius et al. , 196 5) decreased breakdown of microsomal RNA 
(Mycek and Nemeth, 1967; Mycek, In Press), prolongation of ribosomal 
RNA half-life following Pb treatment (Steele, 1970) as well as the increased 
capacity for protein synthesis which occur in livers of Pb-treated rats (Kato 
et al., 1966). 
Inhibition of RNase activity in hypophysectomized, and adrenalectomized 
rats during induction of DME by Pb indicates that intact adrenals or pituitary 
glands are not required for RNase inhibition by Pb. However, these data do 
not exclude the involvement of these glands in the Pb inhibition of RNase of 
intact animals. Ribonuclease inhibition was not as extensive in hypophysec-
tomized or adrenalectomized rats . with the least inhibition of RNase following 
Pb treatment observed in adrenalectomized rats. These findings are consistent 
with the suggestion of Orrenius ~ ~·, (1969) that steroi~ hormones may be 
involved in the maintenance of inducibility of rat liver DME. 
RNase inhibition appears to result from increased levels of a RNase 
inhibitor in cell sar> obtained from livers of Pb-treated rats. Inhibition is 
not due to a direct effe ct of Pb on RNase since addition of Pb does not result 
in RNase inhibition in vitro (Louis-Ferdinand and Fuller, 1970). These 
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results are in agreement with those of Mycek (Biochem. Pharmacol. In Press) 
who was not able to observe inhibition of microsomal nucleic acid degradation 
following direct addition of Pb to the incubation mixture. 
RNase inhibition does not appear to be attributable to the inhibitor 
described by Shortman (1962). He reported that the rat liver RNase inhibitor 
was completely inactivated in the presence of 10-6 molar p-chloromercuribenzoate. 
As a result of the inactivation of RNase inhibitor, latent RNase was activated. 
Mycek (Biochem. Pharmacol. In Press) reported that PCMB concentrations in 
excess of 10 - 3 molar stimulated breakdown of endogenous microsomal nucleic 
acid in preparations from control and Pb-treated rats. However, microsomal 
RNA breakdown in preparations from Pb-treated rats following in vitro addition 
of PCMB was still less than control values. 
Inhibition of RNase may play a dominant role in the induction by Pb of 
DME in hypophysectomized animals, since no stimulation of RNA polymerase 
activity is observed in nuclei of Pb-treated rats (Nebert and Gelboin, 1969; 
Wilson et al., 1967). Inhibition of RNA degradation may account for the en-
hancement of microsomal amino acid incorporating activity (Jondorf ~al., 
1966) and stimulation of drug metabolism observed in hypophysectomized 
rats (Conney, 1961) following administration of Pb. 
Inhibition of RNase might be attributed to dilution of RNase activity re-
sulting from increases in non-RNase liver microsomal protein. However, this 
is not likely since microsomal protein content is increased only 1. 5 fold 
after induction with 5 doses of Pb (100 mg/kg) (Orrenius et al., 1965). 
Greater increases (viz. 5-times) in microsomal protein would conceivably 
be required for dilution to account for the RNase inhibiti~n which was ob-
served 24 hours following a single dose of Pb. It is difficult to demonstrate 
significant increases in microsomal protein 24 hours after a single dose of Pb. 
Since microsomal protein is increased only 1. 5 fold, dilution would account 
for only a 33 percent inhibition of RNase rendering it unlikely that the RNase 
inhibition observed in these studies can be attributed to dilution of RNase 
specific activity by microsomal protein. 
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Competitive Inhibition ~ D-Amphetamine o.f Oxidative Demethylation. 
D-Amphetamine sulfate competitively inhibited PCMA demethylation 
by hepatic 9000 x g supernatant fractions prepared from male and female 
rats. This finding confirms and extends earlier observations (Lal et al., 
1970) concerning amphetamine inhibition of hexobarbital oxidase activity. 
Major sex differences in sensitivity to amphetamine inhibition of DME were not 
apparent since the amphetamine inhibition constants for the two preparations 
were similar. This inhibition did not appear to be attributable to interference 
by amphetamine with NADPH-generation since inhibition was obtained when 
NADPH was added directly in place of the generating system. Comparison of 
control male and female rat liver PCMA demethylase kinetic constants (Table 7) 
indicated that PCMA demethylation proceeded at a higher maximum velocity in 
preparations from male rats . Apparent sex Wfferences in substrate dependence 
of PCMA demethylase are reflected by the respective Km values (male (0. 25) 
female (0. 49 mMolar) PCMA). Shenkman et~·, (1967) have reported similar sex 
differences in hexobarbital oxidase activity. The data indicate that sex differ-
ences in apparent PCMA demethylase maximal velocities are approximately 
half those observed with hexobarbital oxidase. 
As mentioned earlier, it has been reported that alternate substrates 
of microsomal drug metabolizing enzymes can competitively inhibit the metabolism 
of one ru1other. Since d-amphetamine is hydroxylated in vivo the competitive 
inhibition of PCMA demethylation reported here may be attributed to competition 
by amphetamine as an alternate substrate. This does not appear to be the 
situation since it has been reported that neither microsomal preparations 
(Groppetti and Costa, 1969) nor 10, 000 x g rat liver sup~rnatants (Dingle and 
Bass, 1969) metabolize cl-amphetamine to any appreciable extent. However, 
the data do not exclude the possibility that amphetamine may otherwise interact 
with microsomal drug metabolism. 
Amphetamine inhibition of hexobarbital oxidase is observed at inhibitor 
concentrations similar to those used in this investigation. The apparent 
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amphetamine inhibition constant calculated from the data of Lal et al., (1970) 
viz. 4 x 10-3 Molar is .similar to the amphetamine inhibition constant determined 
in PCMA demethylase studies (viz. 2. 5-2. 7 x 10-3Molar). Other amphetamine 
derivatives inhibit hepatic oxidative demethylation. P-Chloroamphatamine 
-3 -3 (Ki; 0. 4 x 10 Molar) p-hydroxyamphetamine (Ki; 24 x 10 Molar) and 
methamphetamine (Ki; 61 x 10-3Molar) inhibit PCMA demethylation by male 
rat liver 9000 x g supernatant fractions (Louis-Ferdinand~ al. , 19 70). 
Methylphenidate, a related phenethylamine derivative, inhibits imipramine 
metabolism in mouse and rat liver. Inhibition by methylphenidate has been 
reported at concentrations similar to those at which amphetamine and am-
phetamine derivatives inhibit PCMA demethylase. Similar inhibition constants 
for imipramine metabolism, hexobarbital oxidase, or PCMA demethylase may 
be attributable to an interaction by phenethyla,mine derivatives with a common 
component of these enzyme systems. 
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CONCLUSIONS AND SUMMARY 
1) Phenobarbital induction of rat liver microsomal drug metabolism is 
associated with a dose-related inhibition of ribonuclease activity of 
microsomal fractions isolated from these animals, which is not 
attributable to differential lysosomal contamination between pre-
parations from control and Pb-treated animals. 
2) Phenobarbital inhibition of RNase does not require the presence of an 
intact pituitary-adrenal axis nor is the presence of either gland re-
quired for the inhibition of RNase by Pb. The data do not exclude 
the· possibility that the presence of these glands enhances the 
response of intact rats to inducing doses of phenobarbital. 
3) Maximal suppression of Liver Microsomal Ribonuclease Activity is 
an early occurrence during induction of drug-metabolizing enzymes. 
Significant reduction of ribonuclease occurs prior to a significant 
increase in p-chloro-N-methylaniline demethylase activity. An 
inverse relationship exists between PCMA demethylase activity and 
ribonuclease during Pb induction. 
4) Induction of p-nitroanisole demethylation during treatment with 3-
methylcholanthrene does not result in a significant (P >o. 05) inhibition 
of microsomal ribonuclease activity. 
5) Inhibition of ribonuclease is associated ·with the presence of a heat-stable 
inhibitor in the cell sap obtained from livers of phenobarbital-treated rats. 
6) Inhibition of ribonuclease during phenobarbital indt~ction is not attribut-
able to a direct effect of phenobarbital on ribonuclease since addition of 
phenobarbital to the incubation medium does not influence RNase activity. 
7) D-Amphetamine sulfate competitively inhibits p-chloro-N-methylaniline 
demethylation by 9000 x g supernatant fractions rrepared from both male 
and female rat livers. 
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8) These findings are consistent with and support the hypothesis that 
inhibition of RNA degradation occurs during induction of drug 
metabolizing enzymes by phenobarbital. It is proposed that this 
constitutes a major mechanism by which this drug increases liver 
RNA, and enhances protein synthesis and thereby stimulates the 
synthesis of drug metabolizing enzymes. The data provide evidence 
for the concept that the altered degradation of RNA is a drug-vulnerable 
metabolic control mechanism. 
IV. RESULTS 
Inhibition of Ribonuclease During Induc~ion !:?_y Phenobarbital. 
Male rats (weighing 400-550 gms) were treated daily with Pb for 
6 days and sacrificed 24 hours or 72 hours after the last Pb administration. 
When rats were sacrificed 24 hours after the last Pb treatment (100 mg/kg) 
aminopyrine demethylase activity was increased five-fold and the RNase 
activity associated with rat liver microsomes was reduced to 1 to 2% of 
control values (Table 1). When rats were sacrificed 72 hours after termina-
tion of Pb treatment, the magnitude of the total change was not as great as 
observed at 24 hours. Although neither of these values were significantly 
different from the 24 hours values, the RNase appeared to increase while 
aminopyrine demethylase decreased toward control values. When this 
experiment was repeated with microsomes of rats sacrificed 1 day following 
5 daily treatments of Pb at a reduced daily dose of 50 mg/kg stimulation of 
aminopyrine demethylase was again associated with a significant (P _ O. 05) 
reduction of RNase. 
In order to further characterize the suppression of RNase during 
Phenobarbital induction, one dose (100 mg/kg) of Phenobarbital was given 
to 20 male (250-300 gm) rats. Animals were killed at 24 hours intervals for 
5 days. Administration of one dose of Pb (100 mg/kg) to male rats resulted in 
a significant (P~. 05) enha.Ilcement of microsomal oxidative demethylation of 
PCMA after 48 hours which persisted for 4 days (Fig.1). Twenty-four hours 
after Pb treatment, RNase activity of microsomal fractions was reduced to 
the lowest point ~bserved, approximately 20% of control values. Microsomal 
RNase was significantly depressed from control for 4 days. 
As ment~oned earlier RNase activity has been repo~ted to change in 
response to treatment with cortisone or growth hormone. Therefore, the 
following experiment was designed to determine whether intact pituitary or 
adre.nal glands were required for the observed effects of Pb on RNase activity. 
Phenobarbital (50 mg/kg or 2 5 mg/kg twice daily for 4 days)was administered 
to intact, adrenalectomized or hypophysectomized maie rats. Distilled water 
24 
Table 1 
Inhibition of Hepatic Ribonuclease During Induction 
of Microsomal Aminopyrine Demethylase by 
Phenobarbital 
Table la 
Influence of Phenobarbital (100 mg/kg) Administration a 
Percent Aminopyrine Percent 
Ribonucleaseb of Demethylase of 
Group (N) + Mean _ S. E. Control Mean:: S.E. Control 
Control (4) 0.131 ~ o. 056 100 + 17.7_1.7 100 
Killed on 
Day 7 (3) 4+ d 0.00 - 0.002 1. 3 93.4:10,9d 527. 
Killed on 
o. 018 ~ o. 015d + d Day 9 (3) 5.8 72. 2 - 7. 6 408. 
Table lb 
Influence of Phenobarbital (50 mg/kg) Administration e 
25 
b Percent Aminopyrine Percent Ribonuclease of Demethylase of 
Group (N) Mean: S. E. Control + Mean_ S. E. Control 
Control (5) o. 357 ~ o. 039 100 + 8.7_3.2 100 
Phenobarbital 
+ f . Treated (4) 0.197 : o. 007f 55 78.6 - 10.6 904 
aTwo groups of male (400-550 gm) rats were treated with 100 mg/kg 
phenobarbital for 6 days. Controls received distilled water. 
bExpressed . as optical density units at 26 0 mµ/mg microsom·a1 protein/2 0 min. 
cExpressed as mµMoles formaldehyde formed/mg microsomal protein/hr. 
dSignificantly diff~rent (P~0.05) from control, but not from each other (P::;.0.05). 
eOne group of male (375-410 gm)rats was treated ·with 50 mg/kg phenobarbital 
for 5 days. Controls received distilled water. All animals were killed 24 
hours after the last treatment. 
fSignificantly different (P ~ 0. 05) from control. 
Fig. 1 Effecta of Phenobarbitalb on Rat Hepatic Ribonuclease During 
Stimulation of Microsomal Oxidative Demethylation . 
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